BIOA

BioAge Labs, Inc.
5.94 +0.00% 2026-10-29
52-week range
4.81 25.95
1-month-16.2%
3-month-34.3%
1-year-24.7%
vs 50-day-20.5%
vs 200-day-62.6%
Volatility105%
Beta1.79
$ vol/day$5M
ATH26.62
From ATH-77.7%
Next report2026-11-05
Nothing written about BIOA yet. Be the first — call it long or short with an entry we price for you, or post a neutral write-up that takes no side. Create a free account
2026AprJulOct

bought sold · bigger dot, bigger trade · follows the chart’s range

WhenPeople SizeValuePrice
4mo sched 1 $1,576,752 24.17
7mo sched 1 $157,084 17.40
8mo sched 1 $150,890 20.94
9mo sched 1 $139,369 20.06
9mo sched 2 $4,755,743 22.71
10mo sched 1 $95,514 14.25
11mo sched 1 $216,000 12.55
11mo sched 1 $702,060 10.93
1.6y buy 2 $101,376 4.39
2.1y buy 1 $4,329,019 20.32
2.1y buy 1 $8,100,000 20.21
2.1y buy 3 $35,399,970 20.91

Next report 2026-11-05 (Thursday, after close, in 6 days) · EPS estimate -0.63. It has finished the next session higher 62% of the time, average move 4.1%.

Day-after move, last 8 reports, oldest left.

ReportedEst.Actual SurpriseGapDay 1Day 5
2026-08-05 beat -0.62 -0.58 +7.1% -0.7% +2.6% -5.0%
2026-05-08 beat -0.63 -0.52 +17.1% -1.7% +1.0% -0.9%
2026-03-24 miss -0.67 -0.72 -7.7% -0.8% -13.5% -6.1%
2025-11-06 miss -0.51 -0.56 -9.0% -2.7% -2.8% +4.4%
2025-08-06 miss -0.38 -0.60 -57.3% +1.8% -0.2% +3.0%
2025-05-06 beat -0.53 -0.36 +31.8% +0.8% +2.8% -4.8%
2025-03-20 miss -0.66 -1.75 -167.8% -3.2% +2.5% -12.8%
2024-11-07 miss -0.73 -6.70 -812.5% +1.1% +7.6% -11.3%
Model view — historical tendencies for the days ahead, not a forecast
Next 1 day
+0.7%
Next 1 week
+5.5%
Next 1 month
+5.2%
Seasonality
Not enough history
20-year seasonality chart →
Mean reversion
Overbought — RSI(2) at 89
RSI(2) under 15 is oversold (this name has historically bounced); over 85 is overbought. Its dip-buy edge in history is +0.02%/day.
Mean-reversion stats →
1-month breakdown — Market · β 1.79 +5.2%
$5M/day volume 105% volatility -25% 1-year -78% from ATH
52-week range · 5% of the way up · -77% from the high
$4.81$25.95

Not investment advice.